180 related articles for article (PubMed ID: 22781474)
21. Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry.
Collas VM; Dubois C; Legrand V; Kefer J; De Bruyne B; Dens J; Rodrigus IE; Herijgers P; Bosmans JM;
Catheter Cardiovasc Interv; 2015 Sep; 86(3):528-35. PubMed ID: 25963917
[TBL] [Abstract][Full Text] [Related]
22. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
Kasel AM; Shivaraju A; Schneider S; Krapf S; Oertel F; Burgdorf C; Ott I; Sumer C; Kastrati A; von Scheidt W; Thilo C
J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
[TBL] [Abstract][Full Text] [Related]
23. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
[TBL] [Abstract][Full Text] [Related]
24. Lower cardiovascular mortality with Medtronic CoreValve versus Edwards SAPIEN in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation.
Tarsia G; Smaldone C; Viceconte NG; Osanna RA; Santillo V; Cuda C; Polosa D; Costantino MF; Del Prete G; Pittella G; Scarano E; Cappiello P; Di Natale M; Sisto F; Marraudino N; Lisanti P
Int J Cardiol; 2014 Dec; 177(2):520-2. PubMed ID: 25218818
[No Abstract] [Full Text] [Related]
25. Transcatheter aortic valve replacement in patients with anomalous left circumflex coronary artery.
Ujihira K; Raval AN; Wolff MR; Osaki S
J Card Surg; 2019 Jun; 34(6):503-505. PubMed ID: 31021012
[TBL] [Abstract][Full Text] [Related]
26. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation.
Gasparetto V; Fraccaro C; Tarantini G; Buja P; D'Onofrio A; Yzeiraj E; Pittarello D; Isabella G; Gerosa G; Iliceto S; Napodano M
Catheter Cardiovasc Interv; 2013 Feb; 81(2):376-83. PubMed ID: 22461314
[TBL] [Abstract][Full Text] [Related]
27. Alternative transarterial access for CoreValve transcatheter aortic bioprosthesis implantation.
Bruschi G; De Marco F; Modine T; Botta L; Colombo P; Mauri S; Cannata A; Fratto P; Klugmann S
Expert Rev Med Devices; 2015 May; 12(3):279-86. PubMed ID: 25672856
[TBL] [Abstract][Full Text] [Related]
28. Aortic valve/root procedures in patients with an anomalous left circumflex coronary artery and a bicuspid aortic valve: anatomical and technical implications.
Liebrich M; Tzanavaros I; Scheid M; Voth W; Doll KN; Hemmer WB
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):114-6. PubMed ID: 25820760
[TBL] [Abstract][Full Text] [Related]
29. Findings of a mixed transfemoral aortic valve implantation program using Edwards and CoreValve devices.
Hernández-Antolín RA; García E; Sandoval S; Almería C; Cuadrado A; Serrano J; de Obeso E; Del Valle R; Bañuelos C; Alfonso F; Guerrero F; Heredia J; Benítez JC; García-Rubira JC; Rodríguez E; Macaya C
Rev Esp Cardiol; 2011 Jan; 64(1):35-42. PubMed ID: 21190774
[TBL] [Abstract][Full Text] [Related]
30. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
31. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
32. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous aortic valve implantation in severe stenosis associated with anomalous origin of the circumflex coronary artery.
Mennuni MG; Pagnotta P; Presbitero P
Eur Heart J; 2011 Jul; 32(13):1687. PubMed ID: 21292679
[No Abstract] [Full Text] [Related]
34. [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].
Zembala M; Wilczek K; Przybylski R; Chodór P; Nadziakiewicz P; Krasoń M; Sadowski J; Dudek D; Kapelak B; Forysz D; Witkowski A; Demkow M; Chmielak Z; Kuśmierski K; Juraszyński Z; Bochenek A; Cisowski M; Trusz-Gluza M; Buszman P; Woś S; Kalarus Z; Poloński L; Gasior M; Opolski G; Ruzyłło W
Kardiol Pol; 2009 Aug; 67(8):936-40. PubMed ID: 19784896
[TBL] [Abstract][Full Text] [Related]
35. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation.
Aktug Ö; Dohmen G; Brehmer K; Koos R; Altiok E; Deserno V; Herpertz R; Autschbach R; Marx N; Hoffmann R
Int J Cardiol; 2012 Sep; 160(1):26-30. PubMed ID: 21458085
[TBL] [Abstract][Full Text] [Related]
36. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
37. Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the Edwards valve or the CoreValve.
Watanabe Y; Hayashida K; Yamamoto M; Mouillet G; Chevalier B; Oguri A; Dubois-Rande JL; Morice MC; Teiger E; Lefèvre T
Am J Cardiol; 2013 Sep; 112(5):707-13. PubMed ID: 23751936
[TBL] [Abstract][Full Text] [Related]
38. First-in-man assessment of a dedicated guidewire for transcatheter aortic valve implantation.
Roy DA; Laborde JC; Sharma R; Jahangiri M; Brecker SJ
EuroIntervention; 2013 Jan; 8(9):1019-25. PubMed ID: 23339807
[TBL] [Abstract][Full Text] [Related]
39. A cardiologist's nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication.
Shatila W; Krajcer Z
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1198-1199. PubMed ID: 29226577
[TBL] [Abstract][Full Text] [Related]
40. Two-year outcomes for patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve implantation.
Codner P; Assali A; Dvir D; Vaknin-Assa H; Porat E; Shapira Y; Kupershmidt M; Bental T; Battler A; Sagie A; Kornowski R
Am J Cardiol; 2013 May; 111(9):1330-6. PubMed ID: 23415022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
